Having effective therapeutics is going to be increasingly important when it comes to confronting Covid-19 and the evolution of new variants. First detected in Japan, the R1 variant is the newest strain of COVID-19 that contains “multiple spike protein mutations”, that could enable it to bypass the antibody protection present in those who are fully vaccinated. Despite the low number of infections, former Harvard Medical School professor William A. Haseltine believes the new mutations found in the R.1 variant could allow it to spread more easily. The professor said the five variations found in R.1 can lead to “increased resistance to antibodies,” in an article written in Forbes earlier this week.
Continue reading “Ivermectin as a Prophylactic and Treatment for COVID-19”